| Pharmaceutical active ingredients: |
| Insulin Zinc Suspension Human crystalline |
| Available forms, composition and doses of Ultratard HM: |
| Injectable; Injection; Insulin Zinc Suspension Human crystalline 100 IU / mlInjectable; Injection; Insulin Zinc Suspension Human crystalline 40 IU / ml |
| Ultratard HM medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB01 - Insulin (Human)A10AC01 - Insulin (Human)A10AD01 - Insulin (Human)A10AE01 - Insulin (Human)A10AF01 - Insulin (Human) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novo NordiskJDH Pharmaceutical |
| Related documents and information about Ultratard HM: |
| Ultratard prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Humuline Ultralong | Insulin Zinc Suspension Human biosynthetic crystalline | Eli Lilly |
| Novolin GE Ultralente | Insulin Zinc Suspension Human biosynthetic prolonged | Novo Nordisk |
| Humuline Zink | Insulin Zinc Suspension Human crystalline | Eli Lilly |
| Humutard Ultra | Insulin Zinc Suspension Human crystalline | Eli Lilly |
| Insulin Ultratard HM | Insulin Zinc Suspension Human crystalline | Novo Nordisk |
| Biohulin Lenta | Insulin Zinc Suspension Human monocomponent | Novo Nordisk |
| Novolin U | Insulin Zinc Suspension Human monocomponent | Novo Nordisk |
| Monotard HM | Insulin Zinc Suspension Human monocomponent amorphous; Insulin Zinc Suspension Human monocomponent crystalline | Novo Nordisk; JDH Pharmaceutical |
| Biohulin Ultralenta | Insulin Zinc Suspension Human monocomponent crystalline | Novo Nordisk |
| Human Monotard | Insulin Zinc Suspension Human recombinant | Novo Nordisk |